A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease

Completed · Phase 2 · Has a placebo group

Conditions studied: Stable Coronary Artery Disease

In brief

The goal of this study is to find out if a drug called selatogrel (ACT-246475) can prevent platelets from binding together when administered by an injection under the skin in the thigh or in the belly. Another goal is to know how fast and for how long selatogrel (ACT-246475) works and if there is a difference if the drug is injected in the thigh or in the belly. This study will also help to find out more about the safety of this new drug.

Key facts

Study ID
NCT03384966
Run by
Viatris Innovation GmbH
People needed
346
Starts
2018-01-24
Expected to finish
2018-09-18
Last updated by the study team
2026-07-29

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.